Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Unresectable Desmoid Fibromatosis: early-phase trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Unresectable Desmoid Fibromatosis: 1 US clinical trial tracked, none currently recruiting.

Unresectable Desmoid Fibromatosis is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Children's Oncology Group, running 1 of these trials.

Enrollment posture brief

Registry condition unresectable-desmoid-fibromatosis

OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Unresectable Desmoid Fib (th…0%
Open-enrollment share among volume-matched conditions near Unresectable Desmoid Fibromatosis

Unresectable Desmoid Fibromatosis has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Unresectable Desmoid Fibromatosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Unresectable Desmoid Fibromatosis is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Unresectable Desmoid Fibromatosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Nirogacestat Drug
1 trials
Echocardiography Test Procedure
1 trials
Magnetic Resonance Imaging Procedure
1 trials
Computed Tomography Procedure
1 trials
Biospecimen Collection Procedure
1 trials

US sites by state

Facility locations filed on Unresectable Desmoid Fibromatosis trials. A trial with sites in several states counts in each.

Delaware 1 trials
Connecticut 1 trials
Colorado 1 trials
California 1 trials
Arizona 1 trials
Arkansas 1 trials
Alabama 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Unresectable Desmoid Fibromatosis page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Unresectable Desmoid Fibromatosis trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Children's Oncology Group sponsors the most Unresectable Desmoid Fibromatosis trials on record, review their full trial history before evaluating a specific study. See Children's Oncology Group's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Unresectable Desmoid Fibromatosis condition card totals 1 registered trials; most-linked intervention Nirogacestat; top US site state Delaware. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.